Amoxicillin Clavulanate: Clinical Evidence & Trials
Amoxicillin Clavulanate is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.
Penicillins have decades of evidence as first-line agents for streptococcal, pneumococcal, and other susceptible bacterial infections.
Evidence Strength
Level A (Strong) for group A streptococcal pharyngitis, community-acquired pneumonia (susceptible strains), MSSA skin infections, and UTI.
Key Clinical Trial Findings
- •Rheumatic fever prevention — penicillin prophylaxis reduces recurrent streptococcal pharyngitis and subsequent acute rheumatic fever by >80%; WHO recommends benzylpenicillin secondary prophylaxis
- •Cochrane 2013 (pharyngitis) — penicillin reduces symptom duration by ~1 day vs placebo; primary benefit is rheumatic fever prevention in endemic areas
- •BTS/NICE community pneumonia — amoxicillin recommended first-line for low-severity CAP; comparable efficacy to fluoroquinolones with lower resistance selection pressure
- •MRSA and beta-lactamase producers — flucloxacillin remains first-line for MSSA skin infections; >90% clinical success
- •UTI — amoxicillin-clavulanate achieves >85% eradication in susceptible E. coli strains
Numbers Needed to Treat (NNT)
Streptococcal pharyngitis (1+ day symptom relief): NNT ≈ 6. Rheumatic fever prevention with secondary prophylaxis: NNT ≈ 4. SSTI with flucloxacillin vs placebo: NNT ≈ 3.
Guideline Recommendations
NICE/PHE: amoxicillin designated ACCESS antibiotic (first-choice, use broadly). Flucloxacillin first-choice for MSSA skin infections. Benzylpenicillin IV first-choice for meningococcal disease. Piperacillin-tazobactam designated WATCH antibiotic (use only for serious infections).
Conditions Treated with Amoxicillin Clavulanate
Questions about your medication?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant medications.
Use AI Symptom Checker →